Continual reassessment method with multiple toxicity constraints

DOI10.1093/BIOSTATISTICS/KXQ062MaRDI QIDQ3303685zbMATH OpenOpenAlexWikidataFDO

Authors Shing M. Lee, Bin Cheng, Ying Kuen Cheung

Publication date 4 August 2020

Published in Biostatistics (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1093/biostatistics/kxq062

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Recommendations

• On the consistency of the continual reassessment method with multiple toxicity constraints
• Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
• The Continual Reassessment Method for Multiple Toxicity Grades: A Bayesian Quasi‐Likelihood Approach
• Bayesian Model Averaging Continual Reassessment Method in Phase I Clinical Trials
• Designs foe phase i cancer clinical trials with differentiation of graded toxicity

Cites work

• A Random Walk Rule for Phase I Clinical Trials
• A simple technique to evaluate model sensitivity in the continual reassessment method
• Coherence principles in dose-finding studies
• Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
• Dose Finding for Continuous and Ordinal Outcomes with a Monotone Objective Function: A Unified Approach
• Dose-Finding Based on Multiple Toxicities in a Soft Tissue Sarcoma Trial
• On the Use of Nonparametric Curves in Phase I Trials with Low Toxicity Tolerance
• Risk-group-specific dose finding based on an average toxicity score
• Sequential Implementation of Stepwise Procedures for Identifying the Maximum Tolerated Dose
• Stochastic approximation with virtual observations for dose-finding on discrete levels
• The Continual Reassessment Method for Multiple Toxicity Grades: A Bayesian Quasi‐Likelihood Approach

Cited in

(13)

• A phase I dose-finding study based on polychotomous toxicity responses
• Time-to-event continual reassessment method incorporating treatment cycle information with application to an oncology phase I trial
• Designs foe phase i cancer clinical trials with differentiation of graded toxicity
• On the consistency of the continual reassessment method with multiple toxicity constraints
• A continual reassessment method without undue risk of toxicity
• A generalized calibrated Bayesian hierarchical modeling approach to basket trials with multiple endpoints
• Incorporating patient-reported outcomes in dose-finding clinical trials
• Bayesian modeling of a bivariate toxicity outcome for early phase oncology trials evaluating dose regimens
• Application of the patient-reported outcomes continual reassessment method to a phase I study of radiotherapy in endometrial cancer
• Towards using a full spectrum of early clinical trial data: a retrospective analysis to compare potential longitudinal categorical models for molecular targeted therapies in oncology
• PoD-BIN: a probability of decision Bayesian interval design for time-to-event dose-finding trials with multiple toxicity grades
• Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
• Bayesian Phase 1–2 Designs with Adaptive Rules for Staggering Patient Entry

This page was built for publication: Continual reassessment method with multiple toxicity constraints

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3303685)